©2024 Stanford Medicine
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
Recruiting
I'm InterestedTrial ID: NCT02893293
Purpose
The goal of the project is to evaluate osteonecrosis before and after decompression surgery
with ferumoxytol-enhanced MRI.
Official Title
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
Stanford Investigator(s)
Heike Daldrup-Link
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Eligibility
Inclusion Criteria:
- Osteonecrosis
- planned decompression surgery with autologous stem cell transplant
Exclusion Criteria:
- Contraindications for magnetic resonance imaging
- Hemosiderosis/hemochromatosis ( patients can still be included in the non-ferumoxytol
arm)
Intervention(s):
drug: Ferumoxytol-enhanced magnetic resonance imaging
device: Magentic Resonance Imaging
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Anne Sawyer
650-302-2846